GlassScriptPhysician profile
Jose A Perez Lopez
NPI 1023105202
$2,399.46
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,025 · 2020: $512 · 2021: $372 · 2022: $332 · 2023: $92.36 · 2024: $65.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $748.30 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $664.38 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $214.06 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $170.57 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $167.79 | 2019-2024 | Jardiance |
| Chiesi USA, INC. | $158.91 | 2020-2024 | Cleviprex |
| Pbg Puerto Rico LLC | $118.03 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $65.84 | 2019-2021 | |
| Pfizer Pharmaceuticals LLC | $44.07 | 2019 | |
| Genzyme Corporation | $30.56 | 2023 | |
| Genentech USA, INC. | $16.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Perez Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.